Anticoagulation during ECMO in neonatal and paediatric patients

Area of Science:

• Pediatric critical care medicine
• Cardiopulmonary support technologies
• Hemostasis and thrombosis research

Background:

• Extracorporeal Membrane Oxygenation (ECMO), a form of Extracorporeal Life Support (ECLS), is vital for pediatric and neonatal patients with severe cardiopulmonary failure.
• Systemic anticoagulation is essential during ECMO to prevent thrombosis in the patient and circuit, yet it elevates hemorrhage risk.
• Current coagulation monitoring methods in pediatric ECMO lack robust evidence linking test results to anticoagulant levels and clinical outcomes.

Purpose of the Study:

• To evaluate the correlation between various coagulation test results and actual anticoagulant levels in pediatric ECMO patients.
• To assess the relationship between coagulation test results and clinical outcomes, including thrombosis and hemorrhage, in children undergoing ECMO.
• To identify more reliable methods for monitoring anticoagulation in pediatric ECMO to improve patient safety and treatment efficacy.

Main Methods:

• Systematic review of laboratory and point-of-care coagulation tests used in pediatric ECMO.
• Analysis of existing literature correlating test results with anticoagulant administration and patient outcomes.
• Comparative analysis of different monitoring strategies and their reported effectiveness.

Main Results:

• Evidence demonstrating a strong correlation between standard coagulation test results and therapeutic anticoagulant levels in pediatric ECMO is limited.
• Current monitoring tests show inconsistent predictive value for both thrombotic and hemorrhagic complications.
• Significant heterogeneity exists in coagulation monitoring protocols across pediatric ECMO centers.

Conclusions:

• The current evidence base for coagulation monitoring in pediatric ECMO is insufficient, highlighting a critical gap in clinical practice.
• There is a pressing need for validated, reliable coagulation assays that correlate well with anticoagulant levels and predict clinical outcomes in this vulnerable population.
• Further research is required to establish optimal anticoagulation monitoring strategies for pediatric ECMO to minimize risks and improve survival rates.